Vimarsana
Biggest News Aggregation in the World

Dina Soliman News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Dina Soliman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Dina Soliman Today - Breaking & Trending Today

APO Group - Africa Newsroom / Press release | SaudiVax, Minapharm, and MiGenTra Sign a Memorandum of Understanding towards a Strategic Partnership in Saudi Arabia and the Gulf Cooperation Countries - Vimarsana News

APO Group - Africa Newsroom / Press release | SaudiVax, Minapharm, and MiGenTra Sign a Memorandum of Understanding towards a Strategic Partnership in Saudi Arabia and the Gulf Cooperation Countries

Published: October 4, 2023

SaudiVax, Minapharm, and MiGenTra Sign a Memorandum of Understanding towards a Strategic Partnership in Saudi Arabia and the Gulf Cooperation Countries

Source: africa-newsroom.com
Related Topics:
Saudi ArabiaAl QahirahAl IskandariyahDina SolimanMigentra GmbGroup SaudivaxBusiness Development Licensing Minapharm ContactStrategic Operations Business Development About SaudivaxBouvier Head Corporate DevelopmentMinapharm PharmaceuticalsStrategic PartnershipMigentra SignGulf Cooperation Countries ThisMigentra GmbhGulf Cooperation CountriesMigentra ContactBusiness DevelopmentMinapharm ContactDina Soliman Director Strategic OperationsAbout SaudivaxSaudi BiotechAbout Minapharm PharmaceuticalsMiddle EastAbout Migentra GmbhGene Therapies
Bioventure, Minapharm Pharmaceuticals and MiGenTra Sign an Exclusive Agreement for the Commercialization of Multiple Biosimilar Candidates of Alvotech in the Middle East and Africa - Vimarsana News

Bioventure, Minapharm Pharmaceuticals and MiGenTra Sign an Exclusive Agreement for the Commercialization of Multiple Biosimilar Candidates of Alvotech in the Middle East and Africa

Published: November 30, 2022

/PRNewswire/ -- Bioventure, a Dubai-based pharmaceutical company, Minapharm Pharmaceuticals, a Cairo-based pharmaceutical company, and MiGenTra GmbH, a...

Source: prnewswire.com
Related Topics:
Al QahirahUnited Arab EmiratesAl IskandariyahAshraf RadwanWafik BardissiPrnewswire BioventureDina SolimanLutz HilbrichMigentra GmbRobert WessmanMinapharm PharmaceuticalsNasdaq Us Stock ExchangeBusiness Development LicensingGlobalone Healthcare HoldingYas Holding Healthcare DivisionHealthcare Division Of Yas HoldingBusiness DevelopmentHead Corporate DevelopmentMigentra GmbhMiddle EastChief Executive OfficerYas HoldingHealthcare DivisionNasdaq Iceland First NorthGene Therapies
Minapharm Pharmaceuticals; MiGenTra GmbH: Bioventure, Minapharm Pharmaceuticals and MiGenTra Sign an Exclusive Agreement for the Commercialization of Multiple Biosimilar Candidates of Alvotech in the Middle East and Africa - Vimarsana News

Minapharm Pharmaceuticals; MiGenTra GmbH: Bioventure, Minapharm Pharmaceuticals and MiGenTra Sign an Exclusive Agreement for the Commercialization of Multiple Biosimilar Candidates of Alvotech in the Middle East and Africa

Published: November 30, 2022

BERLIN, CAIRO and DUBAI, UAE, Nov. 30, 2022 /PRNewswire/ -- Bioventure, a Dubai-based pharmaceutical company, Minapharm Pharmaceuticals, a Cairo-based pharmaceutical company, and MiGenTra GmbH

Source: finanznachrichten.de
Related Topics:
Al QahirahUnited Arab EmiratesAl IskandariyahAshraf RadwanWafik BardissiPrnewswire BioventureDina SolimanLutz HilbrichMigentra GmbRobert WessmanMinapharm PharmaceuticalsNasdaq Us Stock ExchangeBusiness Development LicensingGlobalone Healthcare HoldingYas Holding Healthcare DivisionHealthcare Division Of Yas HoldingBusiness DevelopmentHead Corporate DevelopmentMigentra GmbhMiddle EastChief Executive OfficerYas HoldingHealthcare DivisionNasdaq Iceland First NorthGene Therapies
Bioventure, Minapharm Pharmaceuticals and MiGenTra Sign an Exclusive Agreement for the Commercialization of Multiple Biosimilar Candidates of Alvotech in the Middle East and Africa - Vimarsana News

Bioventure, Minapharm Pharmaceuticals and MiGenTra Sign an Exclusive Agreement for the Commercialization of Multiple Biosimilar Candidates of Alvotech in the Middle East and Africa

Published: November 29, 2022

Download logoBioventure, a Dubai-based pharmaceutical company, Minapharm Pharmaceuticals, a Cairo-based pharmaceutical company, and MiGenTra GmbH

Source: african.business
Related Topics:
Al QahirahUnited Arab EmiratesAl IskandariyahAshraf RadwanSarah WandreyWafik BardissiDina SolimanMigentra GmbLutz HilbrichRobert WessmanMinapharm PharmaceuticalsMigentra Press ContactNasdaq Us Stock ExchangeBusiness Development LicensingGlobalone Healthcare HoldingBusiness Development Strategic OperationsCorporate CommunicationsYas Holding Healthcare DivisionHealthcare Division Of Yas HoldingHead Corporate DevelopmentMigentra GmbhMiddle EastChief Executive OfficerGentra ContactGentra Press Contact
Bioventure, Minapharm Pharmaceuticals and MiGenTra Sign an Exclusive Agreement for the Commercializa - Vimarsana News

Bioventure, Minapharm Pharmaceuticals and MiGenTra Sign an Exclusive Agreement for the Commercializa

Published: November 29, 2022

 BERLIN, Germany, CAIRO, Egypt and DUBAI, United Arab Emirates, November 29, 2022 / B3C newswire / -- Bioventure, a Dubai-based pharmaceutical company, Minapharm Pharmaceuticals, a Cairo-based pharmaceutical company, and MiGenTra GmbH, a Berlin-based pharmaceutical company, announced today the signing of a...

Source: pharmiweb.com
Related Topics:
Al QahirahUnited Arab EmiratesAl IskandariyahAshraf RadwanWafik BardissiSarah WandreyDina SolimanLutz HilbrichMigentra GmbRobert WessmanMinapharm PharmaceuticalsMigentra Press ContactNasdaq Us Stock ExchangeBusiness Development LicensingGlobalone Healthcare HoldingBusiness Development Strategic OperationsDelivery Of Health CareCorporate CommunicationsBiosimilar PharmaceuticalsHealthcare Division Of Yas HoldingYas Holding Healthcare DivisionHead Corporate DevelopmentMigentra GmbhMiddle EastChief Executive Officer